Detailed View
ASMB - Assembly Biosciences, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
446,482,656
Adj EBIT (TTM)
-13,547,000
Enterprise Value
424,598,656
Last Price
22.53
Earnings Yield
-3.19%
Return on Capital
-6.76%
Capital
200,511,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 8,213,000 | -11,370,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 42,469,000 | 19,799,000 |
| 2025-09-30 | 10-Q | 2025 | 10,789,000 | -10,883,000 |
| 2025-06-30 | 10-Q | 2025 | 9,626,000 | -11,093,000 |
| 2025-03-31 | 10-Q | 2025 | 9,419,000 | -9,941,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 7,357,000 | -11,532,000 |
| 2024-09-30 | 10-Q | 2024 | 6,845,000 | -10,956,000 |
| 2024-06-30 | 10-Q | 2024 | 8,533,000 | -12,203,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.